Rekha Jhunjhunwala-Backed IKS Health Faces Oppression, Mismanagement Allegations — Exclusive
IPO-bound IKS Health, a healthcare solutions provider backed by prominent investor Rekha Jhunjhunwala, faces allegations of oppression and mismanagement, as per people in the know and a court filing. The allegations stem from a petition filed by two minority shareholders at the National Company Law Tribunal in Mumbai.
The shareholders, who collectively hold 70,000 shares (0.04% of the company's paid-up capital), have raised serious concerns about corporate governance practices and statutory violations within the company.
These shareholders are Tanveer Ahmed, who has held 50,000 shares since 2015 and Rais Ahmed Ali Motlekar with 20,000 shares since 2012.
Allegations In The Petition
The petition alleges that the company has repeatedly failed to stick to mandatory corporate governance norms and provisions under the Companies Act, 2013. The allegations include:
Failure To Issue AGM/EGM Notices: The two shareholders claim that they were deprived of their statutory right to participate in company meetings due to the non-issuance of notices for Annual General Meetings and Extraordinary General Meetings.
Illegal AGMs and Decisions: Resolutions passed during the 16th, 17th, and 18th AGMs, including financial approvals and auditor appointments, have been challenged as illegal. It is pertinent to note here that the statutory auditor appointed is Price Waterhouse, Chartered Accountants LLP.
Exclusion Of Minority Shareholders: The petition accuses the company of engaging in oppressive practices to exclude minority shareholders from decision-making processes.
Breach of Governance Norms: Allegations of violations of corporate governance standards further tarnish the company's image, ahead of its anticipated IPO.
Reliefs Requested By Minority Shareholders
The petitioners seek to nullify resolutions passed during AGMs/EGMs from 2021 to 2024 and even investigate company affairs.
They have requested an investigation into the company's operations to identify irregularities. Furthermore, the petition calls for the removal of current directors and the appointment of independent administrators.
They have also demanded proper oversight for meetings and financial audits going forward and sought immediate interim relief by requesting the tribunal to restrain the company from implementing any resolutions passed in the disputed meetings.
The two shareholders are being represented by Advocate Kausik Chatterjee.
Other Details
Meanwhile, IKS Health has also filed a caveat in the tribunal, people in the know told NDTV Profit.
This is to prevent any development without getting an opportunity to be heard. A query on the issue was sent to IKS Health and all material litigation has been mentioned in the company DRHP filed in August 2024, the people quoted above said. Additionally, the case is yet to be heard or admitted by the company law tribunal.
They did not comment on this new development. Any further responses will be added to this story.
-
India's Troika Of Good Luck | Joining The Dots
A weaker Trump, a cooling AI trade and resilient earnings have put Indian markets back in favour. Rising inflation could spoil the party.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.